2022
DOI: 10.3390/jfb13010030
|View full text |Cite
|
Sign up to set email alerts
|

Investigating Cancerous Exosomes’ Effects on CD8+ T-Cell IL-2 Production in a 3D Unidirectional Flow Bioreactor Using 3D Printed, RGD-Functionalized PLLA Scaffolds

Abstract: Exosomes from cancer cells are implicated in cancer progression and metastasis, carrying immunosuppressive factors that limit the antitumor abilities of immune cells. The development of a real-time, 3D cell/scaffold construct flow perfusion system has been explored as a novel tool in the study of T-cells and exosomes from cancer cells. Exosomes from human lung cancer (H1299 and A549) cells were co-cultured in a unidirectional flow bioreactor with CD8+ T-cells immobilized onto 3D-printed RGD-functionalized poly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 94 publications
(105 reference statements)
0
1
0
Order By: Relevance
“…We must mention the other biocompatible materials reported in different studies in the last decade that have yet to be adapted for VPP techniques but have great potential due to their chemical properties and biocompatibility. Some of these materials are feldspathic ceramic [154], poly(L-lactide) (PLLA) [155], PEG-DMAP [156], chitosan Bioink [157], α,ω-polytetrahydrofuranether-diacrylate (PTHF-DA) [158], trimethylolpropane triacrylate (TMPTMA) [159], nanocrystalline cellulose [160], nanofibrous silk fibroin [161], and zwitterionic hydrogels (Z-gels) [162]. All the biomaterials above show potential for use in 3D-printed tissue engineering builds, and the methods of adapting and implementing their use in the medical field are still under development.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…We must mention the other biocompatible materials reported in different studies in the last decade that have yet to be adapted for VPP techniques but have great potential due to their chemical properties and biocompatibility. Some of these materials are feldspathic ceramic [154], poly(L-lactide) (PLLA) [155], PEG-DMAP [156], chitosan Bioink [157], α,ω-polytetrahydrofuranether-diacrylate (PTHF-DA) [158], trimethylolpropane triacrylate (TMPTMA) [159], nanocrystalline cellulose [160], nanofibrous silk fibroin [161], and zwitterionic hydrogels (Z-gels) [162]. All the biomaterials above show potential for use in 3D-printed tissue engineering builds, and the methods of adapting and implementing their use in the medical field are still under development.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%